Polpharma Group serves as a top-tier pharmaceutical manufacturer in Europe and a reliable partner for pharmaceutical firms globally. With a wide range of products (Rx, CHC, APIs), expert services, and competencies across the value chain, along with extensive knowledge of local CEE/CIS markets, it provides distinct growth opportunities for B2B partners. Collaborating with Polpharma Group offers access to a supportive environment, guidance from skilled professionals, and cutting-edge resources. The company actively seeks partners across various areas of operation, from product development and production to commercial cooperation. Additionally, Polpharma API, a Poland-based CDMO specializing in active pharmaceutical ingredients (APIs), stands as a significant European API supplier, catering to pharmaceutical companies worldwide. The company is in the process of a $45 million manufacturing expansion, incorporating HPAPI and cryogenic technologies, with investments in a pilot plant and R&D capabilities. Operations are set to expand from mid-2023, with full completion expected by 2026.
Products & Services
Acetazolamide
Country
Pharmaceutical Works Polpharma
Country
City
Address
Alendronate Sodium
Alendronate Sodium Hydrate
Country
Pharmaceutical Works Polpharma
Country
City
Address
Aniracetam
Sites
POLPHARMA, S.A
Country
City
Address
Pharmaceutical Works Polpharma S.A.
Country
City
Address
Pharmaceutical Works Polpharma S.A.
Country
City
Address
Polpharma, S.A. Fcbu
Country
City
Ipochem Ltd (part of Polpharma Group)
Country
City
Address